National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

Found 19,249 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1276 out of 1,925

Result pages: prev   1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285   next


VAERS ID: 1338206 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-10
Onset:2021-03-12
   Days after vaccination:30
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, SARS-CoV-2 test, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 23
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210312; Test Name: COVID-19; Test Result: Positive
CDC Split Type: FRPFIZER INC2021527943

Write-up: SARS-CoV-2 infection; Vaccination failure; death; This is a spontaneous report from a contactable pharmacist reporting for a patient downloaded from the Agency Regulatory Authority-WEB FR-AFSSAPS-GR20211204, Safety Report Unique Identifier FR-AFSSAPS-2021037815. An 83-year-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 10Feb2021 (Batch/Lot Number: EJ6788) as 2ND DOSE, SINGLE; and dose 1 intramuscular on 20Jan2021 (Batch/Lot Number: EJ6788) as 1ST DOSE, SINGLE for covid-19 immunisation, age at vaccination unknown. The patient medical history and concomitant medications were not reported. Patient was a symptomatic COVID-19-positive case (12Mar2021). She was a female resident of a residential care home having had the complete vaccine round with COMIRNATY (2 injections, one on 20Jan2021 and one on 10Feb2021, lot EJ6788). Onset of symptoms was on 12Mar2021. Differential diagnosis was a non-identified strain. Patient was admitted to hospital on 15Mar2021 with oxygen treatment. Outcome of the event SARS-CoV-2 infection and Vaccination failure was not recovered. The resident died, from a different primary cause, on 05Apr2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. Lot number has been received.; Reported Cause(s) of Death: died of different primary cause


VAERS ID: 1338213 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-05-09
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC2021559013

Write-up: Adverse event following immunisation with outcome fatal; This is a spontaneous report from a contactable other health professional via the regulatory authority. Regulatory authority report number is 550219. A 79-year-old male patient received bnt162b2 (COMIRNATY, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration on an unspecified date at single doses for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced adverse event following immunization on 09May2021 with outcome of fatal. The Medicine/Onset Time in Days with event ''adverse event following immunization'' reported as 5 days. The patient died in 2021. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Adverse event following immunisation with outcome fatal


VAERS ID: 1338217 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-18
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3001176 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Acute kidney injury, Blood creatinine, Blood potassium, Blood sodium, C-reactive protein, Chest X-ray, Death, Glycosylated haemoglobin, Infection, Pollakiuria, Ultrasound kidney, Urine albumin/creatinine ratio, Urogram, White blood cell count
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 37
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Albuminuria; Confused; Diabetes (present through a longer period); Fall (Fell mutiple times during hospitalisation); Hypertension; Hyperthyroidism; Renal failure (kidney failure had been present for a longer period)
Preexisting Conditions: Medical History/Concurrent Conditions: Polio
Allergies:
Diagnostic Lab Data: Test Name: Creatinine; Result Unstructured Data: Elevating during hospitalisation from 214 ?mol/L to 337 ?mol/L; Test Name: Potassium; Result Unstructured Data: nothing abnormal; Test Name: Sodium; Result Unstructured Data: Nothing abnormal; Test Date: 20210407; Test Name: Thorax X-ray; Result Unstructured Data: small pleural accumulation, no obvious infiltrates; Test Name: C-reactive protein; Test Result: Inconclusive ; Result Unstructured Data: No results were provided.; Test Date: 20210405; Test Name: C-reactive protein; Result Unstructured Data: elevating to 225 mg/L; Test Name: HbA1C; Test Result: Inconclusive ; Result Unstructured Data: No results were provided.; Test Name: Ultrasound kidney; Result Unstructured Data: No drainage obstruction; Test Name: Urine albumin/creatinine ratio; Test Result: Inconclusive ; Result Unstructured Data: No results were provided.; Test Name: CT Urography; Result Unstructured Data: Cholecystolithiasis, normal size kidney; Test Name: Leukocyte count; Test Result: Inconclusive ; Result Unstructured Data: Not convincingly decreasing during hospitalisation
CDC Split Type: DKMODERNATX, INC.MOD20211

Write-up: Kidney failure Can have been present through a longer period.; Death; Infection during hospitalisation increasing infection parameters; Frequent urination; This regulatory authority case was reported by a physician and describes the occurrence of DEATH (Death), ACUTE KIDNEY INJURY (Kidney failure Can have been present through a longer period.), INFECTION (Infection during hospitalisation increasing infection parameters) and POLLAKIURIA (Frequent urination) in an 83-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3001176) for COVID-19 vaccination. The patient''s past medical history included Polio. Concurrent medical conditions included Hyperthyroidism since 30-Mar-2021, Renal failure (kidney failure had been present for a longer period), Hypertension, Albuminuria since 30-Mar-2021, Fall (Fell mutiple times during hospitalisation), Diabetes (present through a longer period) and Confused since 30-Mar-2021. On 18-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. In March 2021, the patient experienced POLLAKIURIA (Frequent urination) (seriousness criterion hospitalization). On 01-Apr-2021, the patient experienced INFECTION (Infection during hospitalisation increasing infection parameters) (seriousness criterion hospitalization). On an unknown date, the patient experienced ACUTE KIDNEY INJURY (Kidney failure Can have been present through a longer period.) (seriousness criteria hospitalization and medically significant). The patient died on 08-Apr-2021. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, ACUTE KIDNEY INJURY (Kidney failure Can have been present through a longer period.), INFECTION (Infection during hospitalisation increasing infection parameters) and POLLAKIURIA (Frequent urination) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, C-reactive protein: 225 (High) elevating to 225 mg/L. On 07-Apr-2021, Chest X-ray: abnormal (abnormal) small pleural accumulation, no obvious infiltrates. On an unknown date, Blood creatinine: 337 (High) Elevating during hospitalisation from 214 ?mol/L to 337 ?mol/L. On an unknown date, Blood potassium: normal (normal) nothing abnormal. On an unknown date, Blood sodium: normal (normal) Nothing abnormal. On an unknown date, C-reactive protein: unknown (Inconclusive) No results were provided.. On an unknown date, Glycosylated haemoglobin: unknown (Inconclusive) No results were provided.. On an unknown date, Ultrasound kidney: normal (normal) No drainage obstruction. On an unknown date, Urine albumin/creatinine ratio: unknown (Inconclusive) No results were provided.. On an unknown date, Urogram: abnormal (abnormal) Cholecystolithiasis, normal size kidney. On an unknown date, White blood cell count: unknown (Inconclusive) Not convincingly decreasing during hospitalisation. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable. This is a case of death in a 83-year-old male subject with a medical history of HTN, DM and Hyperthyroidism, who died 21 days after receiving the first dose of vaccine. Very limited information has been provided at this time. No follow up is possible.; Sender''s Comments: This is a case of death in a 83-year-old male subject with a medical history of HTN, DM and Hyperthyroidism, who died 21 days after receiving the first dose of vaccine. Very limited information has been provided at this time. No follow up is possible.; Reported Cause(s) of Death: Death


VAERS ID: 1338219 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-27
Onset:2021-04-05
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3000489 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Acute coronary syndrome, Dyspnoea, Hypokalaemia, Oedema
SMQs:, Cardiac failure (broad), Anaphylactic reaction (narrow), Angioedema (broad), Myocardial infarction (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Hypokalaemia (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-10
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LOSARSTAD; METOPROLOL; NORVASC; CENTYL MED
Current Illness: Aortic stenosis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DKMODERNATX, INC.MOD20211

Write-up: acute coronary syndrome; Hypokalaemia; Oedema; Dyspnoea; This regulatory authority case was reported by a physician and describes the occurrence of ACUTE CORONARY SYNDROME (acute coronary syndrome), HYPOKALAEMIA (Hypokalaemia), OEDEMA (Oedema) and DYSPNOEA (Dyspnoea) in a 79-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3000489) for COVID-19 vaccination. Concurrent medical conditions included Aortic stenosis. Concomitant products included LOSARTAN POTASSIUM (LOSARSTAD) from 29-Oct-2009 to an unknown date, METOPROLOL from 08-Nov-2010 to an unknown date, AMLODIPINE BESILATE (NORVASC) from 22-Jun-2018 to an unknown date and BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE (CENTYL MED) from 09-Sep-2014 to an unknown date for Hypertension. On 27-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ACUTE CORONARY SYNDROME (acute coronary syndrome) (seriousness criteria death, hospitalization, medically significant and life threatening), HYPOKALAEMIA (Hypokalaemia) (seriousness criteria hospitalization and medically significant), OEDEMA (Oedema) (seriousness criterion hospitalization) and DYSPNOEA (Dyspnoea) (seriousness criterion hospitalization). The patient died on 10-Apr-2021. The reported cause of death was Acute coronary syndrome. An autopsy was performed, but no results were provided. At the time of death, HYPOKALAEMIA (Hypokalaemia), OEDEMA (Oedema) and DYSPNOEA (Dyspnoea) outcome was unknown. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable. This is a case of death in a 79-year-old male subject with unknown medical history of HTN, and Aortic stenosis, who died 14 days after receiving the first dose of vaccine. Based on information received, patient''s rage and risk factors for acute coronary syndrome, the events are assessed as unlikely related to mRNA-1273.; Sender''s Comments: This is a case of death in a 79-year-old male subject with unknown medical history of HTN, and Aortic stenosis, who died 14 days after receiving the first dose of vaccine. Based on information received, patient''s rage and risk factors for acute coronary syndrome, the events are assessed as unlikely related to mRNA-1273.; Reported Cause(s) of Death: Acute coronary syndrome


VAERS ID: 1338222 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-16
Onset:2021-02-19
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute kidney injury, Acute respiratory distress syndrome, Atrioventricular block, Blood bicarbonate, Blood bilirubin, Blood creatine, Blood creatine phosphokinase, Blood lactic acid, Blood potassium, Blood sodium, Bradycardia, Brain natriuretic peptide, C-reactive protein, Cardiac arrest, Cardio-respiratory arrest, Constipation, Echocardiogram, Electrocardiogram, Fibrin D dimer, Haemoglobin, Hyperkalaemia, Hyperlactacidaemia, Investigation, Lipase, Multiple organ dysfunction syndrome, Myalgia, PCO2, PO2, Platelet count, Psychomotor skills impaired, Troponin, White blood cell count, pH body fluid
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Lactic acidosis (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Interstitial lung disease (broad), Arrhythmia related investigations, signs and symptoms (broad), Conduction defects (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (broad), Tumour lysis syndrome (narrow), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), Sepsis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: VALSARTAN HCT; BISOPROLOL; KARDEGIC; PARIET; ZOCOR; SERETIDE; IKOREL; FLUTICASONE PROPIONATE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COPD (smoker who quit $g 20 years ago); Dyslipidaemia; Hypertension arterial; Infarct myocardial (myocardial infarction, stented in 2002,); Polyposis coli (operated colic polyps); Prostate resection; Varicose vein operation (bilateral varicose stripping,)
Allergies:
Diagnostic Lab Data: Test Name: bicarbonates; Result Unstructured Data: Test Result:7.1 mmol/L; Test Name: Bilirubines; Result Unstructured Data: Test Result:6 mg/l; Test Name: Creatine; Result Unstructured Data: Test Result:20.1 mg/l; Test Name: Creatine phosphokinase; Result Unstructured Data: Test Result:168UI/l; Test Name: Lactic acid; Result Unstructured Data: Test Result:13.34 mmol/L; Test Name: Potassium; Result Unstructured Data: Test Result:7.3 mmol/L; Test Name: Sodium; Result Unstructured Data: Test Result:136 mmol/L; Test Name: Brain natriuretic peptide; Result Unstructured Data: Test Result:2002 pg/mL; Test Name: C-reactive protein; Result Unstructured Data: Test Result:<2.90 mg/l; Test Name: Trans-thoracic echocardiogram; Result Unstructured Data: Test Result:Good left ventricular..; Comments: ..no evidence for a pulmonary embolism, good kinetic, preserved ejection fraction, hypovolaemia; Test Name: Electrocardiogram; Result Unstructured Data: Test Result:Bradycardia to wide QRS; Test Name: D-dimers; Result Unstructured Data: Test Result:3.37; Test Name: haemoglobin; Result Unstructured Data: Test Result:10.8 g/dl; Test Name: Chlorine; Result Unstructured Data: Test Result:106 mmol/L; Test Name: glutamate-oxaloacetate-transaminase; Result Unstructured Data: Test Result:327UI/l; Test Name: glutamate-oxaloacetate-transaminase; Result Unstructured Data: Test Result:206 UI/l; Test Name: Lipase; Result Unstructured Data: Test Result:196UI/l; Test Name: partial pressure of carbon dioxide; Result Unstructured Data: Test Result:32.5; Test Name: pH; Result Unstructured Data: Test Result:6.9; Test Name: platelets; Result Unstructured Data: Test Result:235 g/l; Test Name: partial pressure of oxygen; Result Unstructured Data: Test Result:258; Test Name: High-sensitive troponin; Result Unstructured Data: Test Result:81.7 pg/mL; Test Name: Leukocytes; Result Unstructured Data: Test Result:14.2 g/l
CDC Split Type: FRPFIZER INC2021553639

Write-up: acute respiratory distress syndrome; acute renal failure; multi-visceral failure; hyperlactaemia; asystole; Cardio-respiratory arrest; Atrioventricular block; constipation; hyperkalemia; Psychomotor skills impaired/psychomotor slowdown; bradycardia; myalgia; This is as spontaneous report received from a contactable physician downloaded from the regulatory authority. The regulatory authority report number FR-AFSSAPS-LL20212868 An 89 years old male patient receive second dose of BNT162B2 (COMIRNATY), intramuscular, lot not specified, on 16Feb2021 for covid-19 immunization. Patient with a Medical History of dyslipidemia, hypertension, myocardial infarction stented in 2002, chronic obstructive pulmonary disease (smoker who quit $g 20 years ago), bilateral varicose stripping, operated colic polyps, transurethral prostate resection. Concomitant drugs included bisoprolol, acetylsalicylate lysine (KARDEGIC), rabeprazole sodium (PARIET, 10mg), simvastatin (ZOCOR, 40mg), fluticasone propionate/salmeterol xinafoate (SERETIDE, 2X2/day), fluticasone propionate, salmeterol xinafoate (IKOREL), hydrochlorothiazide/valsartan (VALSARTAN HCT 160mg/12.5mg). Historical Vaccine was 1st dose of COMIRNATY in Jan2021 for covid-19 immunization. Thereafter, onset of myalgia, constipation, psychomotor slowdown described by his wife. On 19Feb2021, around 12:00, the patient described violent abdominal pain. He reported to Emergency Room. At the Emergency department: a few minutes after he arrived, cardiac arrest with asystole - no flow < 2 minutes, low flow 10 minutes. orotracheal intubation 7.5 / Adrenalin 5mg/2 ampoules of Bicarb 8.4%. Trans-thoracic echocardiogram: Good left ventricular, no evidence for a pulmonary embolism, good kinetic, preserved ejection fraction, hypovolaemia. Atrioventricular block 3 with new cardiocirculatory arrest no flow 0 low flow 4 minutes. Administration of ISUPREL rapidly increased to 8mg/h (v40). Electrolyte check: correction of hyperkalemia (5). Multiple cardiac arrests < 2 minutes with extreme bradycardia. Summary: Adrenalin 15mg. Vascular filling 4l given the +++hypovolemic profile on the trans-thoracic echocardiography. Bicarb molar 500ml given severe metabolic acidosis. Motor reaction to the pain without contact requiring the introduction of hypnovel + Ultiva + curarisation. Transfer to the intensive care unit. 20Feb2021: persistence of hemodynamic instability, continuation of vascular filling and increase in amines, transition towards a syndrome of multi-visceral failure acute respiratory distress syndrome acute renal failure with hyperkalaemia, hyperlactaemia, palliative situation, comfort care, continuation of end-of-life sedation, no renewal of supportive treatments. 21Feb2021: patient died. Outcome of the events were fatal. It was unknown whether autopsy was done. Scanner: Cranium: No bleeding, no parenchymal anomalies; Thorax: No endoluminal defect in the pulmonary arteries No pleural-pericardial effusion. No adenomegaly. Parenchyma: Subject to kinetic artefacts. Presence of some bilateral condensing infiltrates of a non-specific appearance associated with thickening of the interlobe septa predominant at the apex. Abdomen-pelvis: No peritoneal effusion. No pneumoperitoneum. No individualised collection. No dilation of the pyelocaliceal cavities. Good permeability of the mesenteric arteries. No anomalies of the small intestines. SUMMARY: No pulmonary embolism or evidence of mesenteric ischemia. Electrocardiogram: Bradycardia to wide QRS. Blood panel assessment (in cardiac arrest): Leukocytes 14.2g/l, haemoglobin 10.8g/dL, platelets 235g/l. D-dimers 3.37. pH 6.9, partial pressure of carbon dioxide 32.5, partial pressure of oxygen 258, bicarbonates 7.1mmol/l. Creatine 20.1mg/l, Chlorine 106 mmol/l, Sodium 136mmol/l, Potassium 7.3 mmol/l, Lactic acid 13.34mmol/l,Bilirubines6mg/l,C-reactiveprotein<2.90mg/l, glutamate-oxaloacetate-transaminase 327UI/l, glutamate-oxaloacetate-transaminase 206 UI/l, Creatine phosphokinase 168UI/l, Lipase 196UI/l, Brain natriuretic peptide 2002pg/ml, High-sensitive troponin 81.7pg/ml. other aetiologies: Functional acute renal failure with dehydration and betablocker + angiotensin-converting enzyme inhibitor + calcium inhibitor overdose. The patient was also confused, and could not remember whether or not he had taken his medication. Possible accidental overdose associated with a double dose the previous day? Treatment with adrenaline, filling and bicarbonates. In summary, III atrioventricular block and cardiac-respiratory arrest at Day 3 from vaccination Dose 2 in a patient with a cardiovascular medical history. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Reported Cause(s) of Death: asystole; hyperkalemia; bradycardia; multi-visceral failure; Psychomotor skills impaired/psychomotor slowdown; Cardio-respiratory arrest; Atrioventricular block; Acute respiratory distress syndrome; hyperlactaemia; acute renal failure; myalgia; const


VAERS ID: 1338262 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-03
Onset:2021-04-18
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-04
   Days after onset: 16
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Bone metastases; Hypertension arterial; Type 2 diabetes mellitus
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 20210414; Test Name: febrile; Result Unstructured Data: Test Result:38 Centigrade; Test Date: 20210418; Test Name: Sars-cov-2 test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021553633

Write-up: drug ineffective; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable other hcp downloaded from a regulatory authority-WEB, regulatory authority number FR-AFSSAPS-RN20211289. A 73-years-old male patient received first dose of bnt162b2 (COMIRNATY), intramuscular on 13Feb2021 (Lot Number: EM0477) as 1st dose, single, second dose intramuscular on 03Apr2021 (Lot Number: EJ6788) as 2nd dose, single, for covid-19 immunisation. Medical history included ongoing Bone metastases, ongoing type 2 diabetes mellitus , ongoing Hypertension arterial , covid-19. The patient''s concomitant medications were not reported. Symptoms included flu syndrome (asthenia and febrile 38C) from 14Apr2021, as well as diarrhoea on 22Apr2021. Patient positive for Covid-19. COVID-19 test on 18Apr2021 was positive. On 04May2021, the patient was dead. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19 confirmed by positive COVID-19 test; drug ineffective


VAERS ID: 1338273 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-10-01
Onset:2021-04-13
   Days after vaccination:194
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Angiotensin converting enzyme, Blood pressure measurement, Blood test, Coma scale, Computerised tomogram, Heart rate, Scan brain, Subarachnoid haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-18
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ROSUVASTATIN; ACEBUTOLOL; KARDEGIC; PERINDOPRIL; PERMIXON; TARDYFERON; PANTOPRAZOLE; CALCIUM LEVOFOLINATE; FLUOROURACILE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Adenocarcinoma of colon (Hepatic metastatic colonic adenocarcinoma); Arterectomy (TAVI with arterial resection in 2019); Benign prostatic hyperplasia; Cholecystectomy; Drug allergy (Allergies: EFFERALGAN); Extracorporeal shock wave lithotripsy (2 extracorporeal lithotripsy); Gastrectomy total (for MALT lymphoma in 1996); Hepatic cancer metastatic (Hepatic metastatic colonic adenocarcinoma); Hypertension arterial; Ischaemic heart disease; MALT lymphoma; Metastases to lung (Lieberkuhnien adenocarcinoma diagnosed with synchronous hepatic and pulmonary metastases.); Penicillin allergy; Skin carcinoma (Epithelial carcinomas of the scalp); TAVI (TAVI with arterial resection in 2019); Triple vessel bypass graft (Triple coronary artery bypass surgery in 2012); Urinary calculus (Urinary lithiasis (2 extracorporeal lithotripsy))
Allergies:
Diagnostic Lab Data: Test Name: angiotensin-converting enzyme; Result Unstructured Data: Test Result:929; Test Name: angiotensin-converting enzyme; Result Unstructured Data: Test Result:56; Test Date: 20210413; Test Name: Blood pressure; Result Unstructured Data: Test Result:168/77; Comments: Upon arrival of the Emergency medical assistance service; Test Date: 20210413; Test Name: blood bradykinin concentration; Result Unstructured Data: Test Result:unknown results; Comments: Upon arrival of the Emergency medical assistance service; Test Date: 20210413; Test Name: Glasgow Coma Scale; Result Unstructured Data: Test Result:7; Comments: Upon arrival of the Emergency medical assistance service; Test Name: Computed tomography scan; Result Unstructured Data: Test Result:diminution of the hepatic lesions with thoracic st; Comments: diminution of the hepatic lesions with thoracic stability; Test Date: 20210413; Test Name: Computed tomography scan; Result Unstructured Data: Test Result:Emergency cerebral computed tomography: Fisher 4 s; Comments: Emergency cerebral computed tomography: Fisher 4 sub-arachnoid haemorrhage with damage to the left temporal horn and significant intracranial hypertension.; Test Date: 20210413; Test Name: heart rate; Result Unstructured Data: Test Result:98; Comments: Upon arrival of the Emergency medical assistance service; Test Date: 20210413; Test Name: Cerebral scan; Result Unstructured Data: Test Result:Predominantly peri-mesencephalic meningeal haemorr; Comments: Predominantly peri-mesencephalic meningeal haemorrhage, and in the occipital cortical sulci. Tetra-ventricular hematic flooding leading to upstream hydrocephalus with early transependymal resorption disorders. No aneurism seen in the Willis polygon arteries. Mesencephalic oedema.
CDC Split Type: FRPFIZER INC2021553668

Write-up: Subarachnoid hemorrhage; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-SE20211054 , Safety Report Unique Identifier FR-AFSSAPS-2021052754.Telephone declaration on 29Apr2021, medically confirmed. An 85-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 22Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation; bevacizumab (ZIRABEV), intravenous (IV) drip from 01Oct2020 (Batch/Lot number was not reported) to 08Apr2021, at 5 mg/kg, frequency as every14 days for adenocarcinoma of colon. The patient''s medical history included hypertension arterial; MALT (mucosa-associated lymphoid tissue) lymphoma; Ischaemic heart disease; Benign prostatic hyperplasia; Urinary lithiasis (2 extracorporeal lithotripsy); Epithelial carcinomas of the scalp; Hepatic metastatic colonic adenocarcinoma. Surgeries history also reported Total gastrectomy for MALT lymphoma in 1996; Cholecystectomy in 2006; Triple coronary artery bypass surgery in 2012; and TAVI with arterial resection in 2019. Patient has allergies to PENICILLIN and "EFFERALGAN ?" (Toxic: 0). COVID-19 HISTORY: patient was at risk of developing a severe form of COVID-19, patient was with no history of COVID-19, it was unknown if patient had been tested for COVID-19. ONCOLOGY HISTORY: in Jul2020, Lieberkuhnien adenocarcinoma diagnosed with synchronous hepatic and pulmonary metastases; On 07Sept2020, Multidisciplinary Oncology Digestive meeting: Indication of first chemotherapy of a bio-chemical type plus biotherapy according to the complete molecular biology, then re-evaluation of the surgical project secondarily; On 18Jan2021, Multidisciplinary Oncology Digestive meeting: Assessment after 6 treatments with FOLFOX AVASTIN, significant hypertension and AVASTIN stopped at treatment 5 despite treatment adjustments. Weight loss with poor state of health despite the adapted dosage. Drop in angiotensin-converting enzyme to 56 compared to 929. Computed tomography scan = diminution of the hepatic lesions with thoracic stability. Proposition of maintenance therapy with 5FU hormone therapy. Discussion of reintroduction of BEVACIZUMAB depending on pressure balance; Last chemotherapy treatment on 08Apr2021: Response after 6 treatments with FOLFOX AVASTIN but poor state of health and improved hypertension after dose was adapted. Currently: maintenance with 5Fu plus Bevacizumab with Treatment 1: 11Feb2021, Treatment 2: 25Feb2021, Treatment 3: 11Mar2021, Treatment 4: 25Mar2021, Treatment 5: 08Apr2021. Cure composed of: ZIRABEV (bevacizumab): 5mg/kg, Calcium Levofolinate: 200mg/m?, and Fluorouracile: 400mg/m? slow intravenous plus 2400 mg/m? via mobile diffuser. The patient''s concomitant medications included rosuvastatin 5mg: 0-0-1; acebutolol 200mg: 0.5-0-0; acetylsalicylate lysine (KARDEGIC) 75mg: 0-1-0; perindopril 8mg: 0-0-1; serenoa repens extract (PERMIXON) 160mg: 1-0-1; ferrous sulfate (TARDYFERON) 1-0-0; pantoprazole 20mg: 1-0-0; calcium levofolinate 200mg/m?; and fluorouracil (FLUOROURACILE) 400mg/m? slow intravenous + 2400 mg/m? via mobile diffuser. The patient experienced subarachnoid hemorrhage on 13Apr2021 which resulted in death. The description of the effect and detailed clinical course was follows: On 13Apr2021, treated by the Emergency medical assistance service for neurological issues in a context of metastatic rectal cancer being treated with chemotherapy. Context of balance issues since the previous day (12Apr2021). Last contact with the patient yesterday at 23:00. Patient found at home in a coma since at least this morning. No evidence of a fall or head injury. Upon arrival of the Emergency medical assistance service: Glasgow Coma Scale 7, left hemiparesis with + blood bradykinin concentration. Blood pressure: 168/77. HR: 98. Emergency cerebral computed tomography: Fisher 4 sub-arachnoid haemorrhage with damage to the left temporal horn and significant intracranial hypertension; Neurosurgeon opinion: no surgical evidence or indication selected. IMAGING: Cerebral scan on 13Apr2021: Predominantly peri-mesencephalic meningeal haemorrhage, and in the occipital cortical sulci. Tetra-ventricular hematic flooding leading to upstream hydrocephalus with early transependymal resorption disorders. No aneurism seen in the Willis polygon arteries. Mesencephalic oedema; Urgent neurosurgeon opinion. PROGRESS: patient transferred to the palliative care unit. Death on 18Apr2021. CONCLUSION: patient presented with a meningeal haemorrhage at Day 23 from Dose 1 of COMIRNATY, in a context of chemotherapy for a metastatic adenocarcinoma with treatment 5 of bevacizumab 10 days earlier. The patient died on 18Apr2021. The cause of death was reported as subarachnoid hemorrhage. It was unknown if an autopsy was performed. The outcome of the other events besides subarachnoid hemorrhage was unknown. No follow-up attempts possible. No further information expected. Batch/lot number cannot be obtained.; Reported Cause(s) of Death: Subarachnoid hemorrhage


VAERS ID: 1338276 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-11
Onset:2021-03-25
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9605 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute coronary syndrome, Cardio-respiratory arrest, Ejection fraction, Electrocardiogram, Electroencephalogram, Polymerase chain reaction, Ventricular tachycardia
SMQs:, Torsade de pointes/QT prolongation (narrow), Anaphylactic reaction (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Ventricular tachyarrhythmias (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Acute central respiratory depression (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMOVAN; BIPRETERAX [INDAPAMIDE;PERINDOPRIL ARGININE]; TADENAN; CARDENSIEL
Current Illness: Arrhythmia; Benign prostatic hyperplasia; Hypertension arterial; Obesity
Preexisting Conditions: Medical History/Concurrent Conditions: Angioplasty
Allergies:
Diagnostic Lab Data: Test Date: 20210325; Test Name: left ventricular ejection fraction; Result Unstructured Data: Test Result:at 30 percent %; Test Date: 20210325; Test Name: Electrocardiography; Result Unstructured Data: Test Result:STEMI (ST-Elevation Myocardial Infarction) aspect; Comments: in aVR: angioplasty of the IVA (2 stents) and of the circumflex (one stent); Test Date: 20210325; Test Name: Electrocardiography; Result Unstructured Data: Test Result:a frank regression of the repolarization disorder; Comments: but treatment emergent adverse event brings to light severely-altered left ventricular ejection fraction at 30 percent, major kinetic disorder with septo-apical akinesia, hypokinesia of the lateral wall. No hypertrophy or left ventricular dilation. Non-dilated ascending aorta, type II mitral profile, non-dilated atria, non-dilated right ventricle but kinetic altered, dry pericardium.; Test Date: 20210325; Test Name: electroencephalogram; Result Unstructured Data: Test Result:burst suppression-like line with a poor prognosis; Test Date: 20210327; Test Name: electroencephalogram; Result Unstructured Data: Test Result:artefact line; Test Date: 20210329; Test Name: electroencephalogram; Result Unstructured Data: Test Result:flat line; Test Date: 20210325; Test Name: Polymerase Chain Reaction; Test Result: Negative ; Comments: Negative Severe acute respiratory syndrome COV-2 Polymerase Chain Reaction test result.
CDC Split Type: FRPFIZER INC2021553673

Write-up: Tachycardia ventricular; Non ST segment elevation acute coronary syndrome; Cardio-respiratory arrest; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB [FR-AFSSAPS-ST20211757], Safety Report Unique Identifier [FR-AFSSAPS-2021047013]. A 73-year-old male patient received bnt162b2 (COMIRNATY) intramuscular, administered in Arm Left on 11Mar2021 (Batch/Lot Number: EP9605) as first dose, 0.3 mL, single for covid-19 immunisation. Medical history included ongoing benign prostatic hyperplasia, ongoing obesity, ongoing Hypertension arterial, ongoing arrhythmia/cardiac rhythm disorder, angioplasty of the left anterior descending artery and the convex (a stent). His father died from myocardial infarction and brother had triple bypass surgery. No History of COVID-19. Concomitant medications included zopiclone (IMOVAN); indapamide, perindopril arginine (BIPRETERAX [INDAPAMIDE;PERINDOPRIL ARGININE]); prunus africana extract (TADENAN); bisoprolol fumarate (CARDENSIEL). The patient experienced tachycardia ventricular, non ST segment elevation acute coronary syndrome and cardio-respiratory arrest, all on 25Mar2021. Clinical course as follows: Patient autonomous at home, lives with his wife. 14 days after Dose 1 of the vaccination (25Mar2021): the patient presented with cardiac respiratory arrest in front of his wife while he was driving his car. He had felt a violent pain in his breast before losing consciousness. When the paramedic firefighters arrived they immediately began cardiac pulmonary resuscitation (NO flow 10 minutes), the automatic defibrillator delivered 2 electric shocks then the patient transitioned to non-shockable rhythm (asystole/dissociation) with 8mg of adrenaline (Low flow of 30 minutes). Electrocardiography: STEMI (ST-Elevation Myocardial Infarction) aspect in aVR: angioplasty of the IVA (2 stents) and of the circumflex (one stent). Very calcified tri-trunk lesion on the coronary network. With no sedation the patient did not present with signs of waking no corneal reflex but presented with spontaneous ventilation as well as several episodes of diarrhoea. Negative Severe acute respiratory syndrome COV-2 Polymerase Chain Reaction test result. Progress: Noradrenalin taken for hypotension; ventricular tachycardia bursts regressed with Cordarone. Electrocardiography on 25Mar2021 showed a frank regression of the repolarization disorder but treatment emergent adverse event brings to light severely-altered left ventricular ejection fraction at 30 percent, major kinetic disorder with septo-apical akinesia, hypokinesia of the lateral wall. No hypertrophy or left ventricular dilation. Non-dilated ascending aorta, type II mitral profile, non-dilated atria, non-dilated right ventricle but kinetic altered, dry pericardium. No sign of waking up: Electroencephalogram on 25Mar2021: burst suppression-like line with a poor prognosis; electroencephalogram of 27Mar2021: artefact line, electroencephalogram of 29Mar2021: flat line. Poor neurological prognosis, decision to stop treatment on 31Mar2021, with extubation, heavy sedation and comfort care. Death on 01Apr2021 at 13:19. file discussed with the patient s general practitioner who specified that the patient presented with numerous risk factors, comorbidities (history of resolved severe cardiac rhythm disorder, obesity, hypertension). Conclusion: cardiorespiratory arrest on ACS-ST+ 14 days after D1 with fatal outcome. The patient died on 01Apr2021. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: cardiopulmonary arrest on SCA ST +


VAERS ID: 1338311 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-05-14
Onset:2021-05-14
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW4109 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-14
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021555125

Write-up: Death; This is a spontaneous report from a contactable physician received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-APPCOVID-20210516102301. Safety Report Unique Identifier GB-MHRA-ADR 25304752. A 57-year-old female patient received Bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) second dose (Batch/lot numer EW4109) on 14May2021 as single dose for COVID-19 immunisation. Medical history included patient has not had symptoms associated with COVID-19, not had a COVID-19 test, unsure if patient is enrolled in clinical trial. Concomitant medications were not reported. The patient was vaccinated under the normal protocol processes. Was observed for 15 minutes and left the premises. Reporter were informed later on the day by the police that the patient has passed away on 14May2021. Not sure if related to the vaccine but needs to be reported. It was unknown if Autopsy Done. The outcome of the event was fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: death


VAERS ID: 1338994 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-01
Onset:2021-05-13
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM4965 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-13
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021548908

Write-up: Death sudden; This is a spontaneous report from a contactable physician from a regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202105141046542160-ORTAS and Sender''s (Case) Safety Report Unique Identifier GB-MHRA-ADR 25297408. A 41-years-old male patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration in May2021 (Batch/Lot Number: EM4965) as single dose (Age at vaccination: unknown) for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. Historical vaccine included COMIRNATY 1st dose, single for covid-19 immunisation. The patient experienced death sudden on 13May2021. Unsure if patient has had symptoms associated with COVID-19. Not had a COVID-19 test. Unsure if patient was enrolled in clinical trial. It is unknown if autopsy was done. No follow-up attempts possible. No further information expected. Information about batch number has been obtained. ; Reported Cause(s) of Death: Death sudden


Result pages: prev   1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1276&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166